• NHS saving £300m with Humira biosimilar deal pharmaphorum
    November 30, 2018
    The NHS is to save £300 million after striking deals with several manufacturers of low cost biosimilars of AbbVie’s Humira inflammatory diseases drug.....
PharmaSources Customer Service